Hangzhou Tiancheng Pharmaceutical

Hangzhou Tiancheng Pharmaceutical Co., Ltd. is a pharmaceutical and medical device manufacturer based in Hangzhou, Zhejiang Province, China. Established in 1993, the company specializes in the production of Class II and Class III medical devices, health foods, and various pharmaceutical formulations, including traditional Chinese medicine (TCM) prepared slices and solid dosage forms. In 2016, the company entered into a strategic equity cooperation with Wanbang Biopharma, a subsidiary of Fosun Pharma, leading to the establishment of Hangzhou Wanbang Tiancheng Pharmaceutical Co., Ltd. to manage its core pharmaceutical assets. The company's product portfolio includes antifungal active pharmaceutical ingredients (APIs) such as miconazole nitrate, specialized TCM treatments like 'Gui Bai Yue' for melasma, and medical supplies including disposable face masks. Hangzhou Tiancheng Pharmaceutical operates GMP-compliant manufacturing facilities and maintains a significant role in the international supply chain for pharmaceutical ingredients.